Industry / innovation partners

Pharmacists are becoming the front door for cardiometabolic care. Policy is still treating them like the back office

The Money Is Moving Into Cancer Screening. The Evidence Still Has to Catch Up.

The Screwworm Border Did Not Hold. Now Mexico and the U.S. Are Betting on Flies.

New nicotine products could become the next major cardiovascular policy failure

In Australia, Cancer Medicine Delays Cost More Than Time

Neurology Is Trying to Stop Nerves Dying, Not Just Treat What Is Left

BMI is not enough. Cardiometabolic risk is hiding in where fat lives

Resistant hypertension may need a diagnostic revolution, not just another drug

When diabetes tech fails, personalised care fails with it
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
